BloombergLean L·
Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.
Read at Bloomberg →
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.
<iframe src="https://statesidedaily.com/embed/cluster/0205d43839def42e836bf53aa6289ec957d7479d" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says"></iframe>